Published in Mykosen on September 01, 1976
Itraconazole, a new triazole that is orally active in aspergillosis. Antimicrob Agents Chemother (1984) 1.83
Comparative effects of cilofungin and amphotericin B on experimental murine candidiasis. Antimicrob Agents Chemother (1990) 1.22
Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat Med (1999) 4.85
Mechanisms of chronic regional postischemic dysfunction in humans. New insights from the study of noninfarcted collateral-dependent myocardium. Circulation (1993) 3.78
Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation (2003) 3.58
The effects of methyl (5-(2-thienylcarbonyl)-1H-benzimidazol-2-yl) carbamate, (R 17934; NSC 238159), a new synthetic antitumoral drug interfering with microtubules, on mammalian cells cultured in vitro. Cancer Res (1976) 3.52
Contribution of mutations in the cytochrome P450 14alpha-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans. Microbiology (1999) 3.19
Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. Circulation (1997) 2.52
Dissociation of cardiomyocyte apoptosis and dedifferentiation in infarct border zones. Eur Heart J (2002) 2.41
Transient expression of phosphatidylserine at cell-cell contact areas is required for myotube formation. J Cell Sci (2001) 2.03
Adult rabbit cardiomyocytes undergo hibernation-like dedifferentiation when co-cultured with cardiac fibroblasts. Cardiovasc Res (2001) 1.85
Itraconazole, a new triazole that is orally active in aspergillosis. Antimicrob Agents Chemother (1984) 1.83
Chronic myocardial hibernation in humans. From bedside to bench. Circulation (1997) 1.73
Photochemical stroke model: flunarizine prevents sensorimotor deficits after neocortical infarcts in rats. Stroke (1989) 1.70
The ultrastructure of Candida albicans after in vitro treatment with miconazole. Sabouraudia (1974) 1.69
Mechanism of action of antifungal drugs, with special reference to the imidazole derivatives. Rev Infect Dis (1981) 1.67
Temporal and spatial variations in structural protein expression during the progression from stunned to hibernating myocardium. Circulation (2004) 1.56
The mechanism of action of the new antimycotic ketoconazole. Am J Med (1983) 1.55
ALCAPA syndrome: an example of chronic myocardial hypoperfusion? J Am Coll Cardiol (1994) 1.52
Histological alterations in chronically hypoperfused myocardium. Correlation with PET findings. Circulation (1994) 1.52
Evidence against interconversion of microtubules and filaments. Nature (1975) 1.47
Promotion of pseudomycelium formation of Candida albicans in culture: a morphological study of the effects of miconazole and ketoconazole. Postgrad Med J (1979) 1.47
The activity of ketoconazole in mixed cultures of fungi and human fibroblasts. Mykosen (1980) 1.47
The preservation of subcellular organelles of Candida albicans with conventional fixatives. J Cell Biol (1974) 1.44
Time course of functional recovery after coronary artery bypass graft surgery in patients with chronic left ventricular ischemic dysfunction. Am J Cardiol (2000) 1.42
The activity of ketoconazole in mixed cultures of leukocytes and Candida albicans. Sabouraudia (1980) 1.37
A direct lead method for the electron microscopic visualization of alkaline phosphatase activity. J Histochem Cytochem (1966) 1.36
Absorption of horseradish peroxidase by the mucosal cells of the duodenum of mouse. I. The fasting animal. J Histochem Cytochem (1968) 1.24
Cytochemical and biochemical studies of yeasts after in vitro exposure to miconazole. Antimicrob Agents Chemother (1977) 1.23
Pathophysiological mechanisms of chronic reversible left ventricular dysfunction due to coronary artery disease (hibernating myocardium). Circulation (1997) 1.22
The separation and characterization of liver plasma membrane fragments circulating in the blood of patients with cholestasis. Clin Chim Acta (1975) 1.22
The inhibition of alkaline phosphatase by L-p-bromotetramisole. Histochemistry (1975) 1.19
Ketoconazole in experimental candidosis. Rev Infect Dis (1981) 1.19
Mitochondrial alterations caused by defective peroxisomal biogenesis in a mouse model for Zellweger syndrome (PEX5 knockout mouse). Am J Pathol (2001) 1.17
R115866 inhibits all-trans-retinoic acid metabolism and exerts retinoidal effects in rodents. J Pharmacol Exp Ther (2000) 1.16
The cytochemical application of new potent inhibitors of alkaline phosphatases. J Histochem Cytochem (1973) 1.16
Degenerative changes in fungi after itraconazole treatment. Rev Infect Dis (1987) 1.14
Influence of the anthelmintic mebendazole on microtubules and intracellular organelle movement in nematode intestinal cells. Am J Vet Res (1975) 1.13
Ultrastructural localization of alkaline phosphatase activity in the absorbing cells of the duodenum of mouse. J Histochem Cytochem (1966) 1.12
Variable effects of explosive or gradual increase of intracranial pressure on myocardial structure and function. Circulation (1993) 1.12
Repeated stunning precedes myocardial hibernation in progressive multiple coronary artery obstruction. J Am Coll Cardiol (1999) 1.10
Time course of atrial fibrillation-induced cellular structural remodeling in atria of the goat. J Mol Cell Cardiol (2001) 1.09
Structural remodelling during chronic atrial fibrillation: act of programmed cell survival. Cardiovasc Res (2001) 1.08
Structural and metabolic correlates of the reversibility of chronic left ventricular ischemic dysfunction in humans. Am J Physiol (1995) 1.08
Dedifferentiated cardiomyocytes from chronic hibernating myocardium are ischemia-tolerant. Mol Cell Biochem (1998) 1.07
Chronic hibernating myocardium: interstitial changes. Mol Cell Biochem (1996) 1.06
Ultrastructural changes in Ascaris suum intestine after mebendazole treatment in vivo. J Parasitol (1975) 1.05
Inhibition of sodium and calcium overload pathology in the myocardium: a new cytoprotective principle. Cardiovasc Res (1993) 1.05
Scanning electron microscopy of Candida albicans after in vitro treatment with miconazole. Antimicrob Agents Chemother (1975) 1.05
Dimethylfumarate is an inhibitor of cytokine-induced nuclear translocation of NF-kappa B1, but not RelA in normal human dermal fibroblast cells. J Invest Dermatol (2001) 1.04
The effects of R U7934 (NSC 238159), a new antimicrotubular substance, on the ultrastructure of neoplastic cells in vivo. Eur J Cancer (1977) 1.03
Ultrastructural correlates of left ventricular contraction abnormalities in patients with chronic ischemic heart disease: determinants of reversible segmental asynergy postrevascularization surgery. Am Heart J (1981) 1.02
Dedifferentiation of atrial cardiomyocytes as a result of chronic atrial fibrillation. Am J Pathol (1997) 1.01
The activity of ketoconazole in clinical isolates of candida albicans cultured in a mycelium promoting medium. Mykosen (1981) 1.01
Dimethylfumarate is an inhibitor of cytokine-induced E-selectin, VCAM-1, and ICAM-1 expression in human endothelial cells. Biochem Biophys Res Commun (1997) 1.01
The formation of annulated lamellae induced by the disintegration of microtubules. J Cell Sci (1975) 1.00
Intranuclear microtubules in lung mast cells of guinea pigs in anaphylactic shock. Lab Invest (1977) 1.00
Ultrastructural and cytochemical correlates of myocardial protection by cardiac hypothermia in man. J Thorac Cardiovasc Surg (1980) 1.00
Delayed ultrastructural changes in duodenal crypts of x-irradiated mice. Int J Radiat Biol Relat Stud Phys Chem Med (1966) 0.99
Only hibernating myocardium invariably shows early recovery after coronary revascularization. Circulation (1996) 0.99
Multivariate analysis of angiographic, histologic, and electrocardiographic data in patients with coronary heart disease. Circulation (1984) 0.98
Fluorescein-labeled tyramide strongly enhances the detection of low bromodeoxyuridine incorporation levels. J Histochem Cytochem (1997) 0.97
Structural changes of atrial myocardium during chronic atrial fibrillation. Cardiovasc Pathol (2000) 0.97
The effects of miconazole on the ultrastructure of Candida albicans. Proc R Soc Med (1977) 0.97
Accumulation of 3-ketosteroids induced by itraconazole in azole-resistant clinical Candida albicans isolates. Antimicrob Agents Chemother (1999) 0.97
Enzyme cytochemistry of Candida albicans. J Histochem Cytochem (1975) 0.95
Morphological changes in cysticerci of Taenia taeniaeformis after mebendazole treatment. J Parasitol (1975) 0.94
Evidence for decreased coronary flow reserve in viable postischemic myocardium. Circ Res (1990) 0.94
In vitro and in vivo activities of the novel azole antifungal agent r126638. Antimicrob Agents Chemother (2004) 0.94
Oxatomide, a new orally active drug which inhibits both the release and the effects of allergic mediators. Experientia (1977) 0.93
Impaired autoregulation of cerebral blood flow in an experimental model of traumatic brain injury. J Neurotrauma (2000) 0.91
Cardioprotective effects of lidoflazine during 1-hour normothermic global ischemia. Circulation (1981) 0.90
Fine structural localization of acid and alkaline phosphatase activities in the absorbing cells of the duodenum of rodents. Histochemie (1968) 0.90
Cardiomyocyte remodelling during myocardial hibernation and atrial fibrillation: prelude to apoptosis. Cardiovasc Res (1999) 0.90
Atrial high energy phosphate content and mitochondrial enzyme activity during chronic atrial fibrillation. Cardiovasc Res (2000) 0.90
Mitochondrial hydrogen peroxide generation by NADH-oxidase activity following regional myocardial ischemia in the dog. J Mol Cell Cardiol (1989) 0.90
A rapid method for the evaluation of compounds with mitochondria-protective properties. J Neurosci Methods (1999) 0.89
Temporal changes in intracranial pressure in a modified experimental model of closed head injury. J Neurosurg (1998) 0.89
Cardioprotective effects of mioflazine during 1 h normothermic global ischaemia in the canine heart. Cardiovasc Res (1984) 0.89
Isolated rat cardiac myocytes as an experimental model to study calcium overload: the effect of calcium-entry blockers. Life Sci (1986) 0.89
Myocardial protection by R 56865: a new principle based on prevention of ion channel pathology. Am J Physiol (1991) 0.89
Development of a novel fluorescent microsphere technique to combine serial cerebral blood flow measurements with histology in the rat. J Neurosci Methods (2003) 0.89
The antiproliferative activity of all-trans-retinoic acid catabolites and isomers is differentially modulated by liarozole-fumarate in MCF-7 human breast cancer cells. Br J Cancer (1998) 0.88
Changes in ultrastructural calcium distribution in goat atria during atrial fibrillation. J Mol Cell Cardiol (2000) 0.88
The subcellular distribution of calcium and the effects of calcium-antagonists as evaluated with a combined oxalate-pyroantimonate technique. Acta Histochem Suppl (1981) 0.88
Localization of specific phosphatase activities in canine coronary blood vessels and heart muscle. J Histochem Cytochem (1971) 0.88
Flunarizine reduces cerebral infarct size after photochemically induced thrombosis in spontaneously hypertensive rats. Stroke (1988) 0.88
Calcium-shifts in anoxic cardiac myocytes. A cytochemical study. J Mol Cell Cardiol (1986) 0.87
Oxatomide protects Trichinella spiralis infected mice from lethal anaphylaxis. Agents Actions (1978) 0.87
The origin of subendothelial cells in developing coronary collaterals. A cytochemical approach. Virchows Arch A Pathol Pathol Anat (1973) 0.87
Liarozole, an antitumor drug, modulates cytokeratin expression in the Dunning AT-6sq prostatic carcinoma through in situ accumulation of all-trans-retinoic acid. Prostate (1995) 0.87
Topical treatment with CYP26 inhibitor talarozole (R115866) dose dependently alters the expression of retinoid-regulated genes in normal human epidermis. Br J Dermatol (2008) 0.86
Ultrastructural and cytochemical changes in spermatogonia and Sertoli cells of whole-body irradiated mice. Anat Rec (1966) 0.86
The effect of ketoconazole and itraconazole on the filamentous form of Pityrosporum ovale. Acta Derm Venereol (1990) 0.86